MYGN MYRIAD GENETICS INC
Healthcare · In Vitro & In Vivo Diagnostic Substances · Market cap: $542.9M
–
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.
Healthcare · In Vitro & In Vivo Diagnostic Substances · Market cap: $542.9M
–
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.